These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 12168918

  • 21. Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer.
    Veale D, Kerr N, Gibson GJ, Harris AL.
    Cancer Res; 1989 Mar 01; 49(5):1313-7. PubMed ID: 2537147
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy.
    Tahara E, Sumiyoshi H, Hata J, Yasui W, Taniyama K, Hayashi T, Nagae S, Sakamoto S.
    Jpn J Cancer Res; 1986 Feb 01; 77(2):145-52. PubMed ID: 2420773
    [Abstract] [Full Text] [Related]

  • 30. Gastric cancer: the correlation between the clinicopathological factors and patients' survival (I).
    Lazăr D, Tăban S, Dema A, Cornianu M, Goldiş A, Raţiu I, Sporea I.
    Rom J Morphol Embryol; 2009 Feb 01; 50(1):41-50. PubMed ID: 19221644
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intensity of androgen and epidermal growth factor receptor immunoreactivity in samples of radical prostatectomy as prognostic indicator: correlation with clinical data of long-term observations.
    Schäfer W, Funke PJ, Kunde D, Rausch U, Wennemuth G, Stützer H.
    J Urol; 2006 Aug 01; 176(2):532-7. PubMed ID: 16813883
    [Abstract] [Full Text] [Related]

  • 36. Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer.
    Neninger Vinageras E, de la Torre A, Osorio Rodríguez M, Catalá Ferrer M, Bravo I, Mendoza del Pino M, Abreu Abreu D, Acosta Brooks S, Rives R, del Castillo Carrillo C, González Dueñas M, Viada C, García Verdecia B, Crombet Ramos T, González Marinello G, Lage Dávila A.
    J Clin Oncol; 2008 Mar 20; 26(9):1452-8. PubMed ID: 18349395
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
    Yu J, Cheng YY, Tao Q, Cheung KF, Lam CN, Geng H, Tian LW, Wong YP, Tong JH, Ying JM, Jin H, To KF, Chan FK, Sung JJ.
    Gastroenterology; 2009 Feb 20; 136(2):640-51.e1. PubMed ID: 19084528
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study.
    Ma BB, Poon TC, To KF, Zee B, Mo FK, Chan CM, Ho S, Teo PM, Johnson PJ, Chan AT.
    Head Neck; 2003 Oct 20; 25(10):864-72. PubMed ID: 12966511
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.